Market Place
Sourcing Support
Meitheal’s Contepo Receives Approval in US
22 Oct 2025 //
FDA
Micro’s Generics Proparacaine HCl Receives Approval in US
20 Oct 2025 //
FDA
Glaukos’s Epioxa HD Receives Approval in US
17 Oct 2025 //
FDA
Glaukos’s Epioxa Receives Approval in US
17 Oct 2025 //
FDA
Novitium’s Generics Clomiphene Citrate Receives Approval in US
17 Oct 2025 //
FDA
Alembic’s Generics Triamcinolone Receives Approval in US
17 Oct 2025 //
FDA
BPI’s Generics Trimethobenzamide HCl Receives Approval in US
16 Oct 2025 //
FDA
Novast’s Generics Conjugated Estrogens Receives Approval in US
15 Oct 2025 //
FDA
Sino’s Generics Sitagliptin Receives Tentative Approval in US
15 Oct 2025 //
FDA
Macleods’s Dapagliflozin Receives Tentative Approval in US
15 Oct 2025 //
FDA
Cipla’s Generics Bictegravir Receives Tentative Approval in US
14 Oct 2025 //
FDA
Amneal’s Generics Epinephrine Receives Approval in US
14 Oct 2025 //
FDA
Ajanta’s Generics Dapagliflozin Receives Tentative Approval in US
14 Oct 2025 //
FDA
Methodist’s Generics Gallium68 Edotreotide Receive Approval in US
10 Oct 2025 //
FDA
Rubicon’s Generics Chlorpromazine HCl Receives Approval in US
10 Oct 2025 //
FDA
Cipla’s Generics Emtricitabine Receives Tentative Approval in US
10 Oct 2025 //
FDA
Apotex’s Generics Cladribine Receives Tentative Approval in US
08 Oct 2025 //
FDA
Sun Pharma’s Generics Xeljanz Receives Tentative Approval in US
08 Oct 2025 //
FDA
Alkem’s Generics Zirconium Receives Tentative Approval in US
08 Oct 2025 //
FDA
Qilu Pharm’s Generics Afatinib Receives Tentative Approval in US
08 Oct 2025 //
FDA
L Perrigo’s Generics Fexofenadin HCl Receives Approval in US
07 Oct 2025 //
FDA
Sandoz’s Generics Axitinib Receives Tentative Approval In US
07 Oct 2025 //
FDA
Amneal Pharms’s Generics Isotretinoin Receives Approval in US
07 Oct 2025 //
FDA
SQ Innovation’s Lasix Onyu Receives Approval In US
07 Oct 2025 //
FDA
Boehringer Ingelheim’s Jascayd Receives Approval In US
07 Oct 2025 //
FDA
Taro’s Generics Lamotrigine Receives Approval In US
07 Oct 2025 //
FDA
Alkem’s Generics Lidocaine Receives Approval in US
06 Oct 2025 //
FDA
Hetero’s Generics Olmesartan Medoxomil Receives Approval in US
06 Oct 2025 //
FDA
Lotus’s Generics Nintedanib Receives Tentative Approval In US
06 Oct 2025 //
FDA
Zydus Lifesciences’s Generics Deflazacort Receives Approval in US
03 Oct 2025 //
FDA
Accord’s Generics Clomiphene Citrate Receives Approval in US
03 Oct 2025 //
FDA
Aurobindo Pharma’s Generics Naproxen Receives Approval in US
03 Oct 2025 //
FDA
Dr Reddys’s Generics Docosanol Receives Approval in US
03 Oct 2025 //
FDA
Celltrion’s Biologics Eydenzelt Receives Approval in US
02 Oct 2025 //
FDA
Bionpharma’s Generics Etravirine Receives Approval in US
02 Oct 2025 //
FDA
Amneal’s Generics Labetalol Hydrochloride Receives Approval in US
02 Oct 2025 //
FDA
FDC’s Generics Pilocarpine Hydrochloride Receives Approval in US
02 Oct 2025 //
FDA
Steriscience’s Generics Vancomycin HCl Receives Approval in US
02 Oct 2025 //
FDA
Annora`s Generics Mirtazapine Receives Approval in US
02 Oct 2025 //
FDA
Macleods’s Generics Metformin Receives Tentative Approval in US
01 Oct 2025 //
FDA
Changzhou`s Generics Doxycycline Receives Approval in US
01 Oct 2025 //
FDA
Dr Reddys`s Generics Prednisone Receives Approval in US
01 Oct 2025 //
FDA
Annora`s Generics Bupropion Hydrochloride Receives Approval in US
01 Oct 2025 //
FDA
Eli Lilly`s Inluriyo Receives Approval in US
25 Sep 2025 //
FDA
Crinetics`s Palsonify Receives Approval in US
25 Sep 2025 //
FDA
Stealth Biotherapeutics`s Forzinity Receives Approval in US
19 Sep 2025 //
FDA
Qilu`s Generics Cyclosporine Receives Approval in US
15 Sep 2025 //
FDA
Cipla`s Generics Glucagon Receives Approval in US
15 Sep 2025 //
FDA
Teva`s Generics Macitentan Receives Tentative Approval in US
15 Sep 2025 //
FDA
Xediton Pharma’s Oritiniv Approved in Canada
12 Sep 2025 //
HEALTH CANADA
Hospira`s Generics Potassium Phosphates Receives Approval in US
11 Sep 2025 //
FDA
Macleods`s Generics Potassium Chloride Receives Approval in US
10 Sep 2025 //
FDA
Amneal`s Generics Sodium Oxybate Receives Approval in US
10 Sep 2025 //
FDA
Celltrion’s Biologics Stoboclo Receives Suppl Approval in US
10 Sep 2025 //
FDA
Celltrion’s Biologics Osenvelt Receives Suppl Approval in US
10 Sep 2025 //
FDA
Horizon`s Biologics Tepezza Receives Suppl Approval in US
09 Sep 2025 //
FDA
Aurobindo’s Generics Deferasirox Receives Approval in US
08 Sep 2025 //
FDA
Epic’s Generics Ivermectin Receives Approval in US
08 Sep 2025 //
FDA
Aurobindo’s Generics Prochlorperazine Receives Approval in US
08 Sep 2025 //
FDA
Alembic`s Generics Phytonadione Receives Approval in US
08 Sep 2025 //
FDA
